Inventor · disambiguated record
Alejandro Dorenbaum
Also filed as: DORENBAUM ALEJANDRO
11 granted patents·13 pending applications·95 citations·filing 2005–2025
91Inventor score
Files withBIOMARIN PHARM INC9MIRUM PHARMACEUTICALS INC8OPPENHEIMER DANIEL I5RENEO PHARMACEUTICALS INC2
Top patents by PatentIndex Score
24 records- 0196US9993481B2Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2016·Granted Jun 12, 2018·11 cites·20 claims
- 0295US7566714B2Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2005·Granted Jul 28, 2009·15 cites·46 claims
- 0394US8067416B2Methods and compositions for the treatment of metabolic disordersOPPENHEIMER DANIEL I·Filed 2009·Granted Nov 29, 2011·12 cites·24 claims
- 0493US9433624B2Methods and compositions for the treatment of metabolic disordersOPPENHEIMER DANIEL I·Filed 2011·Granted Sep 6, 2016·10 cites·12 claims
- 0591US11918578B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·2 cites·17 claims
- 0691US11497745B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2021·Granted Nov 15, 2022·3 cites·13 claims
- 0791US11229647B2Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·4 cites·13 claims
- 0891US7612073B2Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuringBIOMARIN PHARM INC·Filed 2008·Granted Nov 3, 2009·16 cites·11 claims
- 0989USRE43797EMethods of administering tetrahydrobiopterinOPPENHEIMER DANIEL I·Filed 2011·Granted Nov 6, 2012·12 cites·28 claims
- 1088US7947681B2Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuringBIOMARIN PHARM INC·Filed 2009·Granted May 24, 2011·10 cites·28 claims
- 1186US2025360127A1Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1285US2024189308A1Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1371US2018256582A1Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2018·Application pending·0 cites
- 1470US11931365B2Use of PPAR-delta agonists in the treatment of diseaseRENEO PHARMACEUTICALS INC·Filed 2023·Granted Mar 19, 2024·0 cites·14 claims
- 1570US2008090832A1Methods and compositions for the treatment of metabolic disordersBIOMARIN PHARM INC·Filed 2006·Application pending·0 cites
- 1668US2022133738A1Genotype and dose-dependent response to an asbti in patients with bile salt export pump deficiencyMIRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1768US2022152022A1Methods for increasing growth in pediatric subjects having cholestatic liver diseaseMIRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1868US2024016809A1Use of ppar-delta agonists in the treatment of diseaseRENEO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1968US2022160726A1Methods for treating cholestasisMIRUM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2059US2013237543A1Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuringBIOMARIN PHARM INC·Filed 2013·Application pending·0 cites
- 2156US2017000793A1Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuringBIOMARIN PHARM INC·Filed 2016·Application pending·0 cites
- 2254US2011281880A1Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuringOPPENHEIMER DANIEL I·Filed 2011·Application pending·0 cites
- 2348US2010009997A1Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrugBIOMARIN PHARM INC·Filed 2008·Application pending·0 cites
- 2448US2009018136A1Methods and compositions for the treatment of vascular diseaseOPPENHEIMER DANIEL I·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alejandro Dorenbaum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →